lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
isoquercitrin basic information |
product name: | isoquercitrin |
synonyms: | quercetin-3-glucoside;quercetin-3-o-glucoside;quercetin 3-o-glucopyranoside;quercetin-3-o-b-glucopyranoside;quercetin-3-o-b-d-glucofuranoside;quercetin-3-o-beta-glucopyranoside;quercetin-3-o-beta-d-glucopyranoside;3-glucosylquercetin |
cas: | 482-35-9 |
mf: | c21h20o12 |
mw: | 464.38 |
einecs: | 244-488-5 |
product categories: | antineoplastic |
mol file: | 482-35-9.mol |
isoquercitrin chemical properties |
storage temp. | −20°c |
msds information |
provider | language |
---|---|
sigmaaldrich | english |
isoquercitrin usage and synthesis |
chemical properties | white to light yellow powder |